Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Foghorn Therapeutics Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 60 | 62 | +2 |
| Shares | 26.3M | 26.3M | +31.5K (+0.1%) |
| Value | $357.4M | $225.7M | −$131.6M (−36.8%) |
New holders (8)
Institutions that held Foghorn Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rockwood Wealth Management, LLC | 124,030 | $1.06M | 0.34% |
| AQR Capital Management LLC | 70,587 | $606.0K | 0.00% |
| Citadel Advisors LLC | 67,692 | $581.0K | 0.00% |
| Victory Capital Management Inc | 37,500 | $322.0K | 0.00% |
| Trexquant Investment LP | 22,197 | $190.0K | 0.01% |
| BNP Paribas Arbitrage, SA | 10,707 | $91.9K | 0.00% |
| Acadian Asset Management LLC | 4,360 | $37.0K | 0.00% |
| Group One Trading, L.P. | 100 | $1.00K | 0.00% |
Sold out (6)
Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Dynamic Technology Lab Private Ltd | 20,551 | $279.0K |
| XTX Topco Ltd | 11,436 | $156.0K |
| Cubist Systematic Strategies, LLC | 209 | $3.00K |
| Signaturefd, LLC | 45 | $1.00K |
| Ellevest, Inc. | 21 | $0 |
| State of Wyoming | 4 | $0 |